Login to Your Account



Pharma: Clinic Roundup


Friday, June 1, 2012
• Eli Lilly and Co., of Indianapolis, and Kowa Pharmaceuticals America Inc., of Montgomery, Ala., reported results from the PREVAIL (Pitavastatin compaREd with praVAstatin in Lowering LDL-C in the U.S.) study, which showed that Livalo (pitavastatin) 4 mg had superior LDL-C reduction compared with pravastatin 40 mg after 12 weeks of therapy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription